Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis

NASDAQ:SBC - Nasdaq - US73245B1070 - Common Stock - Currency: USD

4.56  -0.13 (-2.77%)

After market: 4.5499 -0.01 (-0.22%)

Fundamental Rating

6

Taking everything into account, SBC scores 6 out of 10 in our fundamental rating. SBC was compared to 108 industry peers in the Health Care Providers & Services industry. SBC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SBC is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make SBC suitable for value investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SBC had positive earnings in the past year.
SBC had a positive operating cash flow in the past year.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 20M 40M 60M

1.2 Ratios

SBC has a better Return On Assets (13.39%) than 96.26% of its industry peers.
With an excellent Return On Equity value of 19.37%, SBC belongs to the best of the industry, outperforming 89.72% of the companies in the same industry.
The Return On Invested Capital of SBC (17.57%) is better than 94.39% of its industry peers.
Industry RankSector Rank
ROA 13.39%
ROE 19.37%
ROIC 17.57%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 24.66%, SBC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Operating Margin of SBC (40.37%) is better than 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 85.28%, SBC belongs to the top of the industry, outperforming 97.20% of the companies in the same industry.
Industry RankSector Rank
OM 40.37%
PM (TTM) 24.66%
GM 85.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SBC has more shares outstanding
The debt/assets ratio for SBC is higher compared to a year ago.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

SBC has an Altman-Z score of 5.74. This indicates that SBC is financially healthy and has little risk of bankruptcy at the moment.
SBC's Altman-Z score of 5.74 is amongst the best of the industry. SBC outperforms 87.85% of its industry peers.
The Debt to FCF ratio of SBC is 0.92, which is an excellent value as it means it would take SBC, only 0.92 years of fcf income to pay off all of its debts.
SBC has a better Debt to FCF ratio (0.92) than 89.72% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that SBC is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.06, SBC is doing good in the industry, outperforming 77.57% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.92
Altman-Z 5.74
ROIC/WACC1.97
WACC8.91%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 50M 100M

2.3 Liquidity

SBC has a Current Ratio of 2.79. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of SBC (2.79) is better than 85.98% of its industry peers.
A Quick Ratio of 2.76 indicates that SBC has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.76, SBC belongs to the best of the industry, outperforming 85.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.79
Quick Ratio 2.76
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 249.35% over the past year.
EPS 1Y (TTM)249.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%256.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 45.60% on average over the next years. This is a very strong growth
Based on estimates for the next years, SBC will show a quite strong growth in Revenue. The Revenue will grow by 15.46% on average per year.
EPS Next Y77.65%
EPS Next 2Y45.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.23%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0.2 0.4 0.6

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.29 indicates a correct valuation of SBC.
SBC's Price/Earnings ratio is a bit cheaper when compared to the industry. SBC is cheaper than 78.50% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.63. SBC is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 6.36, which indicates a rather cheap valuation of SBC.
Based on the Price/Forward Earnings ratio, SBC is valued cheaply inside the industry as 97.20% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of SBC to the average of the S&P500 Index (22.68), we can say SBC is valued rather cheaply.
Industry RankSector Rank
PE 16.29
Fwd PE 6.36
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SBC is valued cheaply inside the industry as 95.33% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SBC is valued a bit cheaper than the industry average as 75.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.06
EV/EBITDA 4.6
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

SBC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SBC's earnings are expected to grow with 45.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y45.6%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SBC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (2/21/2025, 8:00:01 PM)

After market: 4.5499 -0.01 (-0.22%)

4.56

-0.13 (-2.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)05-07 2025-05-07
Inst Owners0.04%
Inst Owner ChangeN/A
Ins Owners90.25%
Ins Owner Change-1.6%
Market Cap469.77M
AnalystsN/A
Price Target11.22 (146.05%)
Short Float %0.61%
Short Ratio0.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-92.95%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.46%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)2.77%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.29
Fwd PE 6.36
P/S 2.92
P/FCF 19.06
P/OCF 17.1
P/B 2.29
P/tB 2.54
EV/EBITDA 4.6
EPS(TTM)0.28
EY6.14%
EPS(NY)0.72
Fwd EY15.73%
FCF(TTM)0.24
FCFY5.25%
OCF(TTM)0.27
OCFY5.85%
SpS1.56
BVpS1.99
TBVpS1.8
PEG (NY)0.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.39%
ROE 19.37%
ROCE 29.01%
ROIC 17.57%
ROICexc 45.43%
ROICexgc 58.86%
OM 40.37%
PM (TTM) 24.66%
GM 85.28%
FCFM 15.31%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.92
Debt/EBITDA 0.16
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 35.56%
Profit Quality 62.08%
Current Ratio 2.79
Quick Ratio 2.76
Altman-Z 5.74
F-Score5
WACC8.91%
ROIC/WACC1.97
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)249.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%256.46%
EPS Next Y77.65%
EPS Next 2Y45.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year14.23%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4666.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8678.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11115.3%
OCF growth 3YN/A
OCF growth 5YN/A